Literature DB >> 26028838

A prospective study to assess the levels of interleukin-6 following administration of diclofenac, ketorolac and tramadol after surgical removal of lower third molars.

Puneet Singh1, Sanjay Rastogi2, Mansi Bansal3, Sanjeev Kumar2, Rakesh Singh4, Sumita G Nishad5, Mahendra P Reddy2, Kumar Rakshak Anand2, Saurabh Kumar1, Muhamad Nishad Thayath5.   

Abstract

INTRODUCTION: The surgical removal of impacted third molars involves, trauma to soft and bony tissue and can result in considerable pain, swelling, and trismus. The greater the amount of tissue injury the greater is the amount of inflammation in the perisurgical region. Interleukin-6 (IL-6) is both a pro inflammatory and anti-inflammatory cytokine. It is secreted by T cells and macrophages to stimulate the immune response. IL-6 is also an early marker of tissue damage. In addition to NSAIDs, corticosteroids, opioids also have immunomodulatory effects. AIM: To evaluate the changes in serum IL-6 levels following surgical removal of third molars under local anaesthesia after administration of two NSAIDs diclofenac and ketorolac and opioid tramadol post operatively.
METHODS: Patients undergoing surgical removal of impacted mandibular third molar teeth were randomly assigned to three groups. Each group received one of the three analgesics viz diclofenac 50 mg, ketorolac 10 mg and tramadol 50 mg. The mean levels of IL-6 was then estimated by ELISA.
RESULTS: The results of our study showed that all three drugs i.e. diclofenac, ketorolac and tramadol have properties which can downregulate the production of IL-6 in response to surgical trauma.
CONCLUSION: It is of clinical significance that the suppression of IL-6 values occurs in tramadol group closely following the diclofenac group. Even though the drug ketorolac suppresses the IL-6 levels similar to diclofenac initially but after 7 days tramadol and ketorolac showed similarities in suppression of IL-6 expression which is less compared to diclofenac group.

Entities:  

Keywords:  Diclofenac; Interleukin-6; Ketorolac; Third molar surgery; Tramadol

Year:  2014        PMID: 26028838      PMCID: PMC4444661          DOI: 10.1007/s12663-013-0609-1

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  14 in total

1.  Attenuation of C-reactive protein increases after exodontia by tramadol and ibuprofen.

Authors:  Eman A El-Sharrawy; Ibrahim E El-Hakim; Elham Sameeh
Journal:  Anesth Prog       Date:  2006

2.  Serum interleukin 6 (IL-6) - effect of surgery and under-nutrition.

Authors:  A M Cruickshank; G Jennings; K H Fearon; M Elia; A Shenkin
Journal:  Clin Nutr       Date:  1991       Impact factor: 7.324

3.  Plasma levels of interleukin-6 and interleukin-10 are affected by ketorolac as an adjunct to patient-controlled morphine after abdominal hysterectomy.

Authors:  M H Kim; T S Hahm
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

4.  Variations of interleukin-6 after surgical removal of lower third molars.

Authors:  Carmen López Carriches; José Maria Martínez González; Manuel Donado Rodríguez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2006-11-01

Review 5.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

6.  Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain.

Authors:  Yong-Min Liu; Sheng-Mei Zhu; Kui-Rong Wang; Zhi-Ying Feng; Qing-Lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

7.  Proinflammatory cytokines in patients with neuropathic pain treated with Tramadol.

Authors:  Durval Campos Kraychete; Rioko Kimiko Sakata; Adriana Machado Issy; Olívia Bacellar; Rogério Santos Jesus; Edgar M Carvalho
Journal:  Rev Bras Anestesiol       Date:  2009 May-Jun       Impact factor: 0.964

8.  Circulating interleukin 6 as a useful marker for predicting postoperative complications.

Authors:  Y Oka; A Murata; J Nishijima; T Yasuda; N Hiraoka; Y Ohmachi; K Kitagawa; T Yasuda; H Toda; N Tanaka
Journal:  Cytokine       Date:  1992-07       Impact factor: 3.861

9.  A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for dental extraction pain.

Authors:  Hitesh Mishra; Farhan Ahmad Khan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04

10.  Effects of co-administered dexamethasone and diclofenac potassium on pain, swelling and trismus following third molar surgery.

Authors:  Babatunde Olamide Bamgbose; Jelili Adisa Akinwande; Wasiu Lanre Adeyemo; Akinola Ladipo Ladeinde; Godwin Toyin Arotiba; Mobolanle Olugbemiga Ogunlewe
Journal:  Head Face Med       Date:  2005-11-07       Impact factor: 2.151

View more
  7 in total

Review 1.  New Insights on Tramadol and Immunomodulation.

Authors:  Iqira Saeed; Adam La Caze; Markus W Hollmann; Paul N Shaw; Marie-Odile Parat
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

2.  Comparison of the analgesic efficacy of oral ketorolac versus intramuscular tramadol after third molar surgery: A parallel, double-blind, randomized, placebo-controlled clinical trial.

Authors:  M-A Isiordia-Espinoza; A Pozos-Guillen; R Martinez-Rider; J Perez-Urizar
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

3.  Comparative Study between Preemptive and Postoperative Intra-Articular Injection of Levobupivacaine and Tramadol for Control of Postoperative Pain.

Authors:  Ayman Anis Metry; Ramy M Wahba; George M Nakhla; Fady A Abdelmalek; Milad Z Ragaei; Neven G Fahmy
Journal:  Anesth Essays Res       Date:  2019 Jan-Mar

4.  Variability in the Analgesic Response to Ibuprofen Is Associated With Cyclooxygenase Activation in Inflammatory Pain.

Authors:  Katherine N Theken; Elliot V Hersh; Nicholas F Lahens; Hyo Min Lee; Xuanwen Li; Eric J Granquist; Helen E Giannakopoulos; Lawrence M Levin; Stacey A Secreto; Gregory R Grant; John A Detre; Garret A FitzGerald; Tilo Grosser; John T Farrar
Journal:  Clin Pharmacol Ther       Date:  2019-04-29       Impact factor: 6.875

5.  The harmful effects of acute PM2.5 exposure to the heart and a novel preventive and therapeutic function of CEOs.

Authors:  Lu Dong; Wenping Sun; Fasheng Li; Min Shi; Xianzong Meng; Chunyuan Wang; Meiling Meng; Wenqi Tang; Hui Liu; Lili Wang; Laiyu Song
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

Review 6.  Preferred practice patterns for photorefractive keratectomy surgery.

Authors:  Rajesh Fogla; Gaurav Luthra; Aishwarya Chhabra; Krati Gupta; Ritika Dalal; Pooja Khamar
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

7.  Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations.

Authors:  Ana Henriques Mota; Noélia Duarte; Ana Teresa Serra; António Ferreira; Maria Rosário Bronze; Luísa Custódio; Maria Manuela Gaspar; Sandra Simões; Patrícia Rijo; Lia Ascensão; Pedro Faísca; Ana Silveira Viana; Rui Pinto; Pradeep Kumar; António José Almeida; Catarina Pinto Reis
Journal:  Pharmaceutics       Date:  2020-12-04       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.